Daclatasvir/sofosbuvirLack of efficacy following off label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1911卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17462-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：165 / 165

相关论文

共 50 条

[1] Hydroxychloroquine/sofosbuvirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1941 (1) : 215 - 215
[2] DexamethasoneLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 162 - 162
[3] OmalizumabLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1909 (1) : 440 - 440
[4] Daclatasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2020, 1834 (1) : 93 - 93
[5] EltrombopagLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2025, 2042 (1) : 174 - 174
[6] SorafenibLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2023, 1940 (1) : 384 - 384
[7] OctreotideLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2021, 1859 (1) : 288 - 288
[8] Bamlanivimab/dexamethasoneLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1933 (1) : 110 - 110
[9] Multiple drugsLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2023, 1942 (1) : 198 - 198
[10] DaratumumabLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2022, 1925 (1) : 204 - 204

← 1 2 3 4 5 →